Redmond Asset Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-12,500
| Closed | -$355K | – | 159 |
|
|
2024
Q1 | $355K | Hold |
12,500
| – | – | 0.11% | 133 |
|
|
2023
Q4 | $166K | Sell |
12,500
-716
| -5% | -$9.52K | 0.05% | 155 |
|
|
2023
Q3 | $118K | Hold |
13,216
| – | – | 0.04% | 157 |
|
|
2023
Q2 | $149K | Hold |
13,216
| – | – | 0.05% | 155 |
|
|
2023
Q1 | $152K | Sell |
13,216
-110
| -0.8% | -$1.27K | 0.05% | 159 |
|
|
2022
Q4 | $154K | Buy |
13,326
+158
| +1% | +$1.83K | 0.06% | 164 |
|
|
2022
Q3 | $167K | Sell |
13,168
-23
| -0.2% | -$292 | 0.06% | 164 |
|
|
2022
Q2 | $91K | Hold |
13,191
| – | – | 0.03% | 180 |
|
|
2022
Q1 | $127K | Buy |
13,191
+534
| +4% | +$5.14K | 0.04% | 185 |
|
|
2021
Q4 | $150K | Buy |
12,657
+144
| +1% | +$1.71K | 0.04% | 192 |
|
|
2021
Q3 | $203K | Hold |
12,513
| – | – | 0.06% | 180 |
|
|
2021
Q2 | $263K | Hold |
12,513
| – | – | 0.08% | 178 |
|
|
2021
Q1 | $194K | Buy |
+12,513
| New | +$194K | 0.06% | 186 |
|